[1]
Mascarella, D. et al. 2024. Back to the future: a case series on revisiting onabotulinumtoxinA for chronic migraine management after anti-CGRP therapies failure. Confinia Cephalalgica. 34, 2 (Dec. 2024). DOI:https://doi.org/10.4081/cc.2024.15767.